MedTrace Logo

The Prevalence of Gastro-oesophageal Reflux in Chronic Lung Disease

NCT00697177 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 75

Last updated 2013-02-15

No results posted yet for this study

Summary

Gastric reflux into the oesophagus may further lung damage in respiratory disease. The proportion of adults with chronic lung disease and gastric reflux is unknown. Adults with this disease regularly complete physiotherapy but the contribution of physiotherapy to reflux is unknown. This study will measure gastric reflux in adults with chronic lung disease, using 24 hour acid monitoring. It is anticipated that approximately 50% of adults with chronic lung disease will have gastric reflux. After monitoring, the number of gastric reflux episodes will be calculated. The results will identify the extent of the gastric reflux problem in these patients and will enable appropriate medical treatment and modifications to physiotherapy, which may improve lung function and quality of life.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Annemarie L Lee, BPhys, MPhys · University of Melbourne

  • Brenda M Button, DPhysio, PhD · The Alfred

  • John W Wilson, MBBS, PhD · The Alfred

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-07-31
Primary Completion
2009-06-30
Completion
2009-06-30

Countries

  • Australia

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00697177 on ClinicalTrials.gov